According to the Royal Australian College of General Practitioners (RACGP) guidelines, basal insulin has a lesser risk of hypoglycemia and should be preferred among patients with consistently high fasting blood glucose (FBG) levels [54]. The gene discussed is INS; the disease is Hypoglycemia.